

Lactoferrin is one molecule with many commercial forms, and the forms are not equivalent. That is why two supplements declaring the same ingredient can behave differently, and why the useful question before choosing one is not how much you need, but which one.
It is an iron-binding glycoprotein found in milk and in several secretions. Its activity depends on a fragile three-dimensional structure: it is that structure, not the chemical formula, that does the work. And it is exactly what industrial processing puts to the test.
Origin and purity. The declared purity and the isolation method say a great deal about what else is in the product and how consistent it is from batch to batch.
Iron saturation. Apo, holo and intermediate forms do not behave the same way: bound iron changes the stability of the protein and part of its biological activity.
How much it suffered during processing. Pasteurisation, drying, extreme pH: every step can denature a share of the protein. A certificate of analysis reporting quantity does not tell you how much of that quantity is still active.
What happens to it in the matrix. A powder in a sachet, a tablet with aggressive excipients and an acidic beverage are not the same ingredient in three different packages.
For a supplement there are three questions to answer, and all three can be measured before any clinical work.
Is the protein still intact and active in your formulation, not just in the raw material? Does it stay that way for the whole declared shelf life, under real storage conditions? And is the activity you want to talk about — the effect on gut microbiota, the action on the barrier, selective antimicrobial activity — demonstrated on a model that resembles the context of use?
Good raw material costs more than generic material, and the arithmetic has to be done on active protein content rather than on declared milligrams. You also need an analytical method able to tell intact protein from denatured protein: without it, stability is an opinion. And formulation has less freedom than it would with a more robust ingredient, because every excipient and process choice has to be verified rather than assumed.
Which activity is central to your positioning, and on which model is it demonstrated? What iron saturation do you need, and does the supplier guarantee it batch by batch? Are your matrix and your production process compatible with a fragile protein? And how will you know, twelve months from now, that the product is still active?
In Nutraceuticals we start from the scientific question, not from the protocol: first you establish what decision the data has to support, then you choose the model. With lactoferrin that means measuring residual activity in the final formulation and not only in the raw material, checking it along the shelf life, and demonstrating the declared effect on relevant cellular and microbiological models — intestinal barrier, selective microbial growth, inflammatory response.
If you are considering lactoferrin for a product, the lactoferrin page describes our work on the ingredient; if the point is building evidence around a formulation, ingredient validation is where to start.
Technical content and news from our laboratories, sent when there is something worth saying.